Literature DB >> 21325

Polyanion and complement receptor of the glomerular epithelium. Relationship to pH.

T E Nevins, Y Kim, A F Michael.   

Abstract

Two markers on the surface of glomerular epithelial cells were studied on human and rat tissue. The glomerular polyanion is known to be a sialoglycoprotein present profusely on glomerular epithelial cell surfaces, and it is detected by binding with cationic dyes. This staining is lost after incubation in the pH range 3.8 to 4.4, yet retained at a more acidic or physiologic pH. A receptor for complement is also present on human glomerular epithelial cells. This receptor is also lost as a function of varying pH incubation and this loss parallels the pattern observed for glomerular polyanion. Neuraminidase treatment of renal tissue removes the sialic acid-dependent glomerular polyanion staining but preserves and stabilizes the complement receptor. Both functions are markers of the cell surface of glomerular epithelial cells and behave as peripheral membrane proteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21325

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  5 in total

Review 1.  Glomerular antigens in glomerulonephritis.

Authors:  T J Neale; C B Wilson
Journal:  Springer Semin Immunopathol       Date:  1982

2.  C3b receptors on human glomeruli in vitro. Loss in culture.

Authors:  J I Scheinman; A J Fish; Y Kim; A F Michael
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

3.  Trypan blue inhibition of complement receptor function on various cells.

Authors:  B L Harper; D P Fine; J C Guckian; T Cavallo
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

4.  Lymphohaemopoietic antigens of cultured human glomerular epithelial cells.

Authors:  F J van der Woude; A F Michael; E Muller; G K van der Hem; R L Vernier; Y Kim
Journal:  Br J Exp Pathol       Date:  1989-02

5.  Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens.

Authors:  J L Platt; T W LeBien; A F Michael
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.